Our top pick for
CoreLogic Inc is an information technology services business based in the US. CoreLogic shares (CLGX) are listed on the NYSE and all prices are listed in US Dollars. CoreLogic employs 5,300 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$79.50|
|52-week range||$0.00 - $0.00|
|50-day moving average||$79.66|
|200-day moving average||$79.35|
|Wall St. target price||$75.43|
|Dividend yield||$0.88 (1.11%)|
|Earnings per share (TTM)||$4.06|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2022-06-25)||N/A|
|1 month (2022-06-02)||N/A|
|3 months (2022-04-02)||N/A|
|6 months (2022-01-02)||N/A|
|1 year (2021-07-02)||N/A|
|2 years (2020-07-06)||18.64%|
|3 years (2019-07-05)||84.07%|
|5 years (2017-07-05)||82.93%|
Valuing CoreLogic stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CoreLogic's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
CoreLogic's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 20x. In other words, CoreLogic shares trade at around 20x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
CoreLogic's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.6463. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into CoreLogic's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
CoreLogic's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $506.8 million.
The EBITDA is a measure of a CoreLogic's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.7 billion|
|Operating margin TTM||21.21%|
|Gross profit TTM||$1 billion|
|Return on assets TTM||5.36%|
|Return on equity TTM||35.04%|
|Market capitalisation||$5.9 billion|
TTM: trailing 12 months
Dividend payout ratio: 20.04% of net profits
Recently CoreLogic has paid out, on average, around 20.04% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.65% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), CoreLogic shareholders could enjoy a 1.65% return on their shares, in the form of dividend payments. In CoreLogic's case, that would currently equate to about $0.88 per share.
While CoreLogic's payout ratio might seem low, this can signify that CoreLogic is investing more in its future growth.
CoreLogic's most recent dividend payout was on 14 March 2021. The latest dividend was paid out to all shareholders who bought their shares by 25 February 2021 (the "ex-dividend date").
CoreLogic's shares were split on a 10000:5709 basis on 1 June 2010. So if you had owned 5709 shares the day before before the split, the next day you'd have owned 10000 shares. This wouldn't directly have changed the overall worth of your CoreLogic shares – just the quantity. However, indirectly, the new 42.9% lower share price could have impacted the market appetite for CoreLogic shares which in turn could have impacted CoreLogic's share price.
Over the last 12 months, CoreLogic's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while CoreLogic's is 1.1422. This would suggest that CoreLogic's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
CoreLogic, Inc. , together with its subsidiaries, provides property information, insight, analytics, and data-enabled solutions in North America, Western Europe, and the Asia Pacific. The company operates in two segments, Property Intelligence & Risk Management Solutions (PIRM) and Underwriting & Workflow Solutions (UWS). The PIRM segment combines property information, mortgage information, and consumer information to deliver housing market and property-level insights, predictive analytics, and risk management capabilities. It also offers proprietary technology and software platforms to access, automate, or track the information and assist its clients with decision-making and compliance tools in the real estate and insurance industries. This segment primarily serves commercial banks, mortgage lenders and brokers, investment banks, fixed-income investors, real estate agents, MLS companies, property and casualty insurance companies, title insurance companies, government agencies, and government-sponsored enterprises. The UWS segment combines property, mortgage, and consumer information to provide comprehensive mortgage origination and monitoring solutions, including underwriting-related solutions, and data-enabled valuations and appraisals.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.